Cuihua Liu | Data-informed Decision Making | Best Researcher Award

Dr. Cuihua Liu | Data-informed Decision Making | Best Researcher Award

Bio-Thera Solutions Ltd | China

PUBLICATION PROFILE

Orcid

EARLY ACADEMIC PURSUITS 🎓

Dr. Cuihua Liu’s academic journey laid the foundation for her extraordinary career in the biotech and biopharma industry. She began her studies at Central China Normal University, where she earned her M.Sc. in Bioorganic Chemistry in 1989, under the mentorship of distinguished professors. She then went on to pursue a Ph.D. in Biophysical Chemistry at The University of Western Ontario, Canada, where she worked under the supervision of Dr. Nils O. Petersen. Her doctoral research focused on the design and analysis of dendritic bifunctional ligands and their dynamic properties within biomembranes, providing her with a solid understanding of molecular chemistry and protein interactions. This academic background, combined with postdoctoral research in molecular biology, prepared her for the technical challenges she would face in the biotech industry.

PROFESSIONAL ENDEAVORS 🌐

Dr. Liu’s professional trajectory spans more than 20 years in the biotech and biopharmaceutical industry, with leadership roles in both the U.S. and China. Her career is marked by her ability to translate academic knowledge into practical, real-world solutions in drug development. Dr. Liu has worked for global companies such as Pfizer, Momenta Pharmaceuticals, and Bio-Thera Solutions. She also founded and led several biotech startups, including United-Power Biotechnology Co. Ltd. in Beijing and Huaota Biopharma in Shanghai, showcasing her entrepreneurial spirit and her deep commitment to advancing the biopharma sector. Throughout her career, Dr. Liu has overseen the development of over 50 biologics and non-biologics R&D programs, including the development of antibody biosimilars and novel biologic therapies.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Dr. Liu’s contributions to the biopharma field are vast, particularly in the area of CMC (Chemistry, Manufacturing, and Controls) development and regulatory affairs. She has led the development of critical biologics such as monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and glycoproteins. Dr. Liu’s expertise spans all stages of biologics development, from R&D and process optimization to regulatory filings and commercialization. Her research has focused on improving the manufacturing processes for complex biologics, ensuring compliance with global regulatory standards (such as FDA, EMA, and cFDA), and optimizing the scalability and quality of drug products. She is credited with the successful submission of numerous IND (Investigational New Drug) applications and BLA (Biologics License Applications) that have enabled the approval of biologics across multiple international markets.

IMPACT AND INFLUENCE 🌍

Dr. Liu’s impact on the biopharma industry, particularly in China, is profound. She has been instrumental in guiding Chinese biotech companies through the complex regulatory landscape, ensuring they meet international standards and expand their reach globally. Dr. Liu’s leadership in the development of biosimilars, particularly for blockbuster drugs like Humira and Avastin, has not only advanced the availability of affordable treatments but also paved the way for other biotech companies to follow in her footsteps. Her influence extends beyond corporate leadership, as she has contributed to the globalization of multiple companies by offering strategic consultation on corporate development and quality systems.

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Dr. Liu is a respected researcher with over 25 peer-reviewed international publications and has co-invented over 15 patents. Her work on the characterization of complex biologics, including glycoproteins, monoclonal antibodies, and ADCs, is highly regarded in the scientific community. Her academic contributions have been cited by researchers in both the academic and industrial sectors, establishing her as a thought leader in biopharma development. Dr. Liu’s ability to bridge the gap between academia and industry has helped shape modern approaches to biologics development, particularly in China.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Dr. Liu’s legacy in the biotech and biopharma industry is characterized by her technical expertise, leadership, and entrepreneurial vision. Her pioneering work in biologics development, particularly in the area of biosimilars and novel therapeutics, has significantly contributed to global health. As an independent consultant, Dr. Liu continues to shape the future of the industry, offering her vast knowledge and experience to emerging companies seeking to navigate the complexities of drug development and regulatory approval. Her work will undoubtedly continue to influence the future of biologics and biopharmaceutical innovation, ensuring that the next generation of drugs will be safer, more affordable, and more accessible to patients around the world.

PERSONAL QUALITIES AND LEADERSHIP STYLE 🏅

Dr. Liu is known for her strong leadership skills, exceptional technical expertise, and collaborative approach to team management. She has built and mentored diverse teams throughout her career, fostering an environment of innovation and growth. Her leadership style is characterized by a combination of strategic thinking, technical proficiency, and a hands-on approach to problem-solving. Dr. Liu’s ability to navigate complex challenges and lead teams toward success has made her a respected figure in the biopharma community.

LEGACY IN EDUCATION AND MENTORSHIP 🌱

Dr. Liu has also contributed significantly to the education and mentorship of future leaders in the biopharma industry. She has been an invited speaker at over 50 international conferences and has shared her expertise in various forums, influencing and inspiring countless professionals. Dr. Liu’s legacy extends beyond her personal achievements, as she continues to mentor the next generation of biopharma experts, encouraging them to push the boundaries of scientific discovery and innovation.

TOP NOTES PUBLICATIONS 📚 

Comparative Structure Activity Relationship Characterization of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
    • Authors: Yujie Liu, Jianhua Xie, Zhuxiang Li, Xiong Mei, Di Cao, Shengfeng Li, Linda Engle, Suli Liu, Hans C. Ebbers, Cuihua Liu

    • Journal: BioDrugs

    • Year: 2025-03

Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
    • Authors: Yujie Liu, Jianhua Xie, Zhuxiang Li, Xiong Mei, Di Cao, Shengfeng Li, Linda Engle, Suli Liu, Hans C. Ebbers, Cuihua Liu

    • Journal: BioDrugs

    • Year: 2024-09

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
    • Authors: Yujie Liu, Jianhua Xie, Zhuxiang Li, Xiong Mei, Di Cao, Shengfeng Li, Linda Engle, Suli Liu, Hans C. Ebbers, Cuihua Liu

    • Journal: BioDrugs

    • Year: 2024-07

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
    • Authors: Di Cao, Chunping Deng, Guangying Wang, Xiong Mei, Jianhua Xie, Yuanmei Liu, Yujie Liu, Yili Yang, Shengfeng Li, Cuihua Liu

    • Journal: Drugs in R&D

    • Year: 2023-09

 

Benjamin Teo | Energy and Utilities Analytics | Best Researcher Award

Dr. Benjamin Teo | Energy and Utilities Analytics | Best Researcher Award

Imperial College London | United Kingdom

Publication Profile

Scopus

Orcid

Google Scholar

👨‍🔬 Summary

Dr. Benjamin H. W. Teo is a dedicated researcher with a focus on sustainable energy technologies, adsorption science, and additive manufacturing. Currently a UKRI Postdoctoral Fellow at Imperial College London, he explores solar technology performance and its integration with other renewable systems. Dr. Teo’s research also extends to polymer crystallization, Metal-Organic Frameworks (MOFs), and their applications in energy systems. With over 18 published journal articles and several international conference presentations, he has become a leading expert in his field, combining theoretical modeling with practical, industry-oriented solutions to address climate change.

🎓 Education

Dr. Teo completed his Ph.D. in Mechanical Engineering from Nanyang Technological University (NTU), Singapore (2014-2019). His doctoral research focused on the green synthesis and modulation of MOFs to enhance water adsorption properties for cooling applications. Prior to this, he earned a Bachelor’s degree in Mechanical Engineering with First Class Honours from NTU (2011-2014), and a Diploma in Mechatronics from Temasek Polytechnic, Singapore (2006-2009).

💼 Professional Experience

Dr. Teo’s professional career has been marked by key roles in leading institutions. As a UKRI Postdoctoral Fellow at Imperial College London (Sep 2023 – Present), he investigates solar cell performance in combination with sustainable technologies and conducts advanced heat transfer simulations. From 2019 to 2023, he worked as a Research Fellow at Nanyang Technological University, leading studies on polymer crystallization in additive manufacturing and contributing to industry collaborations. He also held the role of Project Officer (2019) at NTU, where he conducted extensive research on water adsorption in MOFs and zeolites for cooling system applications.

📚 Academic Cites & Publications

Dr. Teo has contributed extensively to the academic community with 18 journal publications, including 10 as the first author. His work covers topics such as MOF-based adsorption cooling systems and additive manufacturing, with publications in prestigious journals like Applied Thermal Engineering and Journal of Industrial and Engineering Chemistry. His research has garnered significant attention, evidenced by citations in high-impact journals. He has also shared his findings at numerous international conferences, including as an invited keynote speaker.

🛠️ Technical Skills

Dr. Teo possesses a wide range of technical skills, including material characterization techniques like X-ray diffraction (XRD), BET nitrogen adsorption, and scanning electron microscopy (SEM). He is proficient in computational modeling, utilizing Grand Canonical Monte Carlo (GCMC) simulations, phase-field modeling, and thermodynamic frameworks via MATLAB. His expertise also extends to additive manufacturing, where he studies polymer crystallization, melt flow viscosity, and their implications for 3D printed materials.

👩‍🏫 Teaching Experience

Dr. Teo has a strong background in teaching, currently serving as a Graduate Teaching Assistant at Imperial College London (Apr 2024 – Present), where he leads revision lectures and tutorials on Fluid Mechanics. He also volunteered as a Tutor at Nanyang Technological University (Aug 2022 – May 2023), receiving exceptional student feedback. As a Research Mentor, he has guided over 30 students through their final-year projects, with many achieving high academic success. Additionally, he taught Gas Turbine Engine Labs and other courses during his time at NTU, earning recognition for his effective teaching.

🔬 Research Interests

Dr. Teo’s research interests include sustainable energy technologies, particularly solar photovoltaic systems and their integration with other green technologies. He is also deeply involved in additive manufacturing, especially in studying polymer crystallization and its impact on the mechanical properties of 3D printed materials. Additionally, his work in adsorption science focuses on the development of MOFs for water adsorption and cooling applications, aiming to enhance energy efficiency and contribute to climate change mitigation strategies.

📚 Top Notes Publications

Mesoscale simulations of spherulite growth during isothermal crystallization of polymer melts via an enhanced 3D phase-field model
    • Authors: Weidong Li, How Wei Benjamin Teo, Kaijuan Chen, Jun Zeng, Kun Zhou, Hejun Du

    • Journal: Applied Mathematics and Computation

    • Year: 2023

Investigation of polyamide 12 isothermal crystallization through the application of the phase‐field model
    • Authors: How Wei Benjamin Teo, Van Thai Tran, Kaijuan Chen, Kim Quy Le, Hejun Du, Jun Zeng, Kun Zhou

    • Journal: Polymers for Advanced Technologies

    • Year: 2023

Effects of build positions on the thermal history, crystallization, and mechanical properties of polyamide 12 parts printed by Multi Jet Fusion
    • Authors: H. W. B. Teo

    • Journal: Virtual and Physical Prototyping

    • Year: 2022

Non-isothermal crystallization behaviour of polyamide 12 analogous to multi-jet fusion additive manufacturing process
    • Authors: H. W. B. Teo

    • Journal: Polymer

    • Year: 2021

Experimental and modeling investigation on the viscoelastic-viscoplastic deformation of polyamide 12 printed by Multi Jet Fusion
    • Authors: H. W. B. Teo

    • Journal: International Journal of Plasticity

    • Year: 2021